VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $608,827 | +19.4% | 18,820 | +5.8% | 0.06% | +11.1% |
| Q4 2022 | $510,005 | -72.6% | 17,795 | -73.8% | 0.05% | -69.5% |
| Q2 2022 | $1,858,000 | -64.9% | 67,845 | -50.9% | 0.18% | -55.9% |
| Q1 2022 | $5,300,000 | +16.3% | 138,195 | -2.9% | 0.40% | +25.3% |
| Q4 2021 | $4,559,000 | -6.2% | 142,325 | -13.7% | 0.32% | -19.6% |
| Q3 2021 | $4,861,000 | -12.9% | 164,965 | +0.5% | 0.40% | -9.1% |
| Q2 2021 | $5,580,000 | +44.1% | 164,215 | +37.8% | 0.44% | +37.3% |
| Q1 2021 | $3,873,000 | -48.2% | 119,180 | -42.5% | 0.32% | -52.4% |
| Q4 2020 | $7,470,000 | -8.4% | 207,385 | -0.5% | 0.67% | -21.5% |
| Q3 2020 | $8,159,000 | -23.9% | 208,360 | -28.7% | 0.85% | -23.3% |
| Q2 2020 | $10,718,000 | – | 292,210 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |